The Journal of Urology
Volume 172, Issue 4, Supplement , Pages 1607-1609, October 2004

THE SIGNIFICANCE OF SERUM ERYTHROPOIETIN LEVELS IN ASSESSING THE SEVERITY OF RENAL DAMAGE IN CHILDREN WITH REFLUX NEPHROPATHY

From the National Children's Hospital and Children's Research Centre, Our Lady's Hospital for Sick Children, University College Dublin, Dublin, Ireland

ABSTRACT 

Purpose:

Erythropoietin (EPO) is the principal factor regulating red blood cell production in humans. It has been shown that EPO gradually decreases with the progression of diabetic nephropathy and may be used as a marker of severity of disease. In vitro studies have shown that interleukin-10 (IL-10) acts synergistically with EPO to increase stimulation of erythroid differentiation and proliferation. We evaluate serum levels of EPO and IL-10 in children with reflux nephropathy (RN).

Materials and Methods:

Serum level of EPO and IL-10 were measured in 32 girls and 22 boys with RN, and in 22 boys and 10 girls who served as healthy controls. Renal scarring was evaluated with 99mTechnetium dimercapto-succinic acid scan. RN was severe (less than 20% uptake) in 16 children, moderate (20% to 40% uptake) in 25 and mild RN (greater than 40% uptake) in 13. Because anemia may further stimulate EPO production we also compared the index Hb (hemoglobin) × EPO in all patients. IL-10 and EPO were measured with standard enzyme-linked immunosorbent assay technique. The unpaired t test was used for statistical analysis.

Results:

There were no statistically significant differences in the serum levels of EPO in children with RN (6.11 ± 0.51 mIU/ml) compared to controls (6.42 ± 0.46 mIU/ml) (p >0.5). Similarly the index Hb × EPO was 75.25 ± 5.65 in children with RN compared to 73.76 ± 5.48 in controls. Mean EPO levels were similar for mild, moderate and severe RN. There was no difference in the serum levels of IL-10 in children with RN (23.14 ± 2.32 pg/ml) compared to controls (22.67 ± 4.13 pg/ml) (p >0.5).

Conclusions:

Although EPO has been reported to be a marker of progressive renal disease in diabetic nephropathy, our data indicate that serum levels of EPO do not reflect the severity of renal parenchymal damage in children with RN.

Key Words::  kidney diseases , erythropoietin , interleukins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Papers Presented at Annual Meeting of the Section on Urology, American Academy of Pediatrics

PII: S0022-5347(05)61319-5

doi:10.1097/01.ju.0000138521.04892.ab

The Journal of Urology
Volume 172, Issue 4, Supplement , Pages 1607-1609, October 2004